Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983-93 and 1994-98 at European Group for Blood and Marrow Transplantation centres
about
Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectivesComparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trialsToxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patients.Overall survival and fungal infection-related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts.Allogeneic transplantation for multiple myeloma: further evidence for a GVHD-associated graft-versus-myeloma effect.Novel therapeutic approaches for multiple myeloma.Molecular monitoring of minimal residual disease in patients with multiple myeloma.Treatment advances in multiple myeloma.Stem cell transplantation for multiple myeloma.Graft vs. host disease and graft vs. myeloma effect after non-myeloablative allogeneic transplantation.The role of allogeneic transplantation in non-Hodgkin's lymphoma.Effect of acute and chronic GVHD on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma.Allo-SCT for multiple myeloma: a review of outcomes at a single transplant center.Targeted therapy in multiple myeloma.Current treatment options for myeloma.Advances in the management of myeloma.Role of allogeneic stem cell transplantation in multiple myeloma.Stem cell transplantation in multiple myeloma.Plasmacytoma relapses in the absence of systemic progression post-high-dose therapy for multiple myeloma.Cure of multiple myeloma -- more hype, less reality.Role of stem cell transplantation in myeloma.Current therapeutic uses of lenalidomide in multiple myeloma.Myeloablative allogeneic stem cell transplantation for advanced stage multiple myeloma: very long-term follow up of a single center experience.Late relapses following reduced intensity allogeneic transplantation in patients with multiple myeloma: a long-term follow-up studyThe current status of reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma.Mini-Midi-Maxi? How to harness the graft-versus-myeloma effect and target molecular remission after allogeneic stem cell transplantation.The allogeneic dilemma.Survival from multiple myeloma in England and Wales up to 2001.In pursuit of the allo-immune response in multiple myeloma: where do we go from here?The allogeneic graft-versus-cancer effect.Clinical impact of chromosomal aberrations in multiple myeloma.Novel agents to improve outcome of allogeneic transplantation for patients with multiple myeloma.Guidelines for the diagnosis and management of multiple myeloma 2011.Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions.Evolving therapeutic paradigms for multiple myeloma: back to the future.Tandem autologous vs autologous plus reduced intensity allogeneic transplantation in the upfront management of multiple myeloma: meta-analysis of trials with biological assignment.Monoclonal antibody-based immunotherapy for multiple myeloma.Allogeneic hematopoietic stem cell transplantation for multiple myeloma: what place, if any?Allogeneic transplantation in multiple myeloma.
P2860
Q26799104-D1F40E34-6969-42C1-A243-F4D61EF0B196Q27024932-0B19C2DC-302A-49B0-916C-B87870ECBA45Q33402680-E19BD858-8C12-4DCD-B7FE-416642DF8BA1Q33723583-6B9E55C7-BBB9-4D1B-83FD-524DFA87F97AQ34487409-2685C672-939D-4945-AF89-2BA3449BF760Q34487436-403AD613-131A-49A1-A28B-2BB10A2D1515Q35170935-3CB5EFF7-6D7F-45BA-A4CE-A940D56496C1Q35668677-C0C6495E-2532-4E6B-9E3A-FDC1B5887921Q35688848-E035903D-2E38-4FEA-9866-60647BE2928FQ35692626-6030BFB3-C937-4232-916A-4A9D6EEA7CA2Q35820989-79B7D91B-AA43-49AB-A0EA-D573948707D5Q36003103-86048D7B-798C-4EA2-8864-45F19C345E9BQ36013444-287DE475-AAE0-460D-B6B3-F11685873BF5Q36035436-453D7C07-FE86-4769-A72B-4408BE280C70Q36108614-8B9D13C7-AA6B-486F-9071-764FF477478EQ36163971-DB6D19AF-77E0-4078-BC5C-FB7F74FD1A2EQ36174361-353BFC0B-CD48-4CDD-A367-6514A9D30649Q36185617-4D407C26-3BEC-4043-92D7-162520655C2EQ36269933-6665C5F2-7CDE-49EE-BCDB-D50A8956E7DBQ36271114-DEE14C21-D290-4BD9-A06E-B8BE7BD56551Q36301128-11B62A31-273D-45E2-9229-76ED1DAA5730Q36308971-1F073ACF-DBC2-49AE-B923-4205F9D1B119Q36376450-EB4CA791-E819-4CB9-B7AF-6DA60226317EQ36481199-F7939A59-D009-448A-BD60-70B84B00B000Q36524579-30149F21-7494-41D1-BF70-13B3221639E0Q36556492-253D5A64-CCF5-49AA-B928-9B7C7D814588Q36849339-6DF1F816-52F8-44EA-A1A7-79030CB2AD89Q36902825-C38EBEB1-52E5-4BE1-871D-D44285CD7AFCQ36917738-1F40474B-7330-4728-8893-7C030A4FE41CQ37349835-EE03C5CA-CB2D-48E3-AE97-ED235FEF2721Q37593125-AA412907-0147-422B-B256-610F9804AE9DQ37821077-396DB0ED-8711-4F5F-98CB-013864CC9BD7Q37822742-3255D99E-8F92-422E-94E2-74F2023F3A5DQ37875193-B3B01F7B-072C-47A8-A736-8A8A10CF6980Q38014834-014A4791-1DDA-45EB-90C5-F623B8A7FA13Q38033590-D7FFCC28-FAF1-45AC-945F-25AB97CA0251Q38042273-58DC0F4A-DB22-4725-92F2-F68D60028AB5Q38050507-DA026539-C769-45D7-A57A-8EC0170FFD06Q38154518-226BBA80-FA96-4BD8-8C62-63AF3AB8D0BEQ38162280-6B9F3151-A6CE-4D82-A53C-F078DCA2DFDE
P2860
Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983-93 and 1994-98 at European Group for Blood and Marrow Transplantation centres
description
im April 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 April 2001
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2001
@uk
name
Progress in allogeneic bone ma ...... Marrow Transplantation centres
@en
Progress in allogeneic bone ma ...... Marrow Transplantation centres
@nl
type
label
Progress in allogeneic bone ma ...... Marrow Transplantation centres
@en
Progress in allogeneic bone ma ...... Marrow Transplantation centres
@nl
prefLabel
Progress in allogeneic bone ma ...... Marrow Transplantation centres
@en
Progress in allogeneic bone ma ...... Marrow Transplantation centres
@nl
P2093
P50
P1476
Progress in allogenic bone mar ...... Marrow Transplantation centres
@en
P2093
A Bacigalupo
A Schattenberg
A de Laurenzi
B Björkstrand
D Niederwieser
European Group for Blood and Marrow Transplantation
H Svensson
P304
P356
10.1046/J.1365-2141.2001.02726.X
P407
P577
2001-04-01T00:00:00Z